Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation

Neuroprotective drugs and selective monoamine oxidase inhibitors can slow down the progression and improve symptoms of Parkinson’s disease (PD). Since there is an implication of oxidative stress in the pathophysiological mechanisms of the disease, the compounds possessing an ability to reduce the ox...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastassova, Neda, Aluani, Denitsa, Kostadinov, Anton, Rangelov, Miroslav, Todorova, Nadezhda, Hristova-Avakumova, Nadya, Argirova, Maria, Lumov, Nikolay, Kondeva-Burdina, Magdalena, Tzankova, Virginia, Yancheva, Denitsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354139/
https://www.ncbi.nlm.nih.gov/pubmed/33818516
http://dx.doi.org/10.4103/1673-5374.309843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354139/
https://www.ncbi.nlm.nih.gov/pubmed/33818516
http://dx.doi.org/10.4103/1673-5374.309843

Ejemplares similares